Morgans Blog | Morgans

Ex-100 Reporting Season Playbook

28 July 2020, 1:00 PM

The quality of performance this period will likely be distorted by COVID-19 impacts and new accounting standards (ie. AASB16). We identify 20 stocks that we believe will likely have positive share price reactions to their results, six that will have negative reactions, and the remainder neutral.

Podcast: Bank to the future - Michael Fredericks, Founder and CEO of Fu (Ep 7)

By Chris Titley

28 July 2020, 11:00 AM

Fu is a first of it’s kind lifestyle management platform allowing millennials to better understand their cashflow needs. Fu has built predictive analysis over the top of their users data, to assist with their day to day living.

ASX 100 Reporting Season Playbook

By Nathan Lead

28 July 2020, 11:00 AM

We preview our expectations for 56 stocks that will report their results in August.

Technical analysis: 27 July 2020

By Violeta Todorova

27 July 2020, 12:00 PM

Cardno, Insurance Australia, Shine Justice, Bank of Queensland and Credit Corp Group.

Reporting Season Preview: Healthcare Sector

By Derek Jellinek

27 July 2020, 10:30 AM

Morgans Senior Analysts Derek Jellinek and Scott Power share a preview of the healthcare sector ahead of the August 2020 reporting season.

COVID-19: Pathway to a vaccine

By Derek Jellinek

23 July 2020, 2:50 PM

Executives from five drug companies leading the COVID-19 vaccine race (ie AstraZeneca (LON; AZN), Johnson & Johnson (NYSE: JNJ), Merck (NYSE: MRK), Moderna (NASDAQ: MRNA), and Pfizer (NYSE: PFE)) appeared in front of the US House Energy and Commerce Oversight and Investigations Subcommittee to talk about their progress in developing a product the entire world desperately needs.